BioNTech founders Uğur Şahin and Özlem Türeci (Photo by: Horst Galuschka/picture-alliance/dpa/AP Images)
BioNTech founders' oncology startup rolls up its second PhIII win for Astellas
A cancer drug from one of the power couples of biotech has snagged a win in its second Phase III study, opening up a straight …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
